GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] we are measuring plateau at the wrong time and calling it noise — 45 comments in the full submission. View in context.
4.5k
c/semaglutide·submitted 1 year ago by u/quiet_moderator

[Discussion] we are measuring plateau at the wrong time and calling it noise

Discussionbranch of 13 comments

Thinking out loud about this: we are measuring plateau at the wrong time and calling it noise. On the "everybody ends up at 2.4" claim, which comes up every few weeks. The escalation schedule in the trials was designed to get people to a fixed study dose. Real use is not a trial. The dose that keeps your appetite…

Read the full submission and all 45 comments →

This branch

13 comments, started 1 year ago
u/ismael_chukwu319 points·1 year ago

The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.

replysharereportpermalink
u/helga_vermeulen152 points·1 year ago

week 20 plateau is the most predictable thing in this entire board

replysharereportpermalink
u/elodie_grimaldi79 points·1 year ago

stalling at 0.25mg is information, not a verdict

replysharereportpermalink
u/hugo_bergstrom127 points·1 year ago

Careful. A four-week stall is inside normal variation and treating it as failure is how people escalate for no reason.

replysharereportpermalink
u/pavel_nkemelu164 points·1 year ago

Genuine question — is the appetite effect still there, or is it just the scale that has paused?

replysharereportpermalink
u/wanjiru_varga88 points·1 year ago

Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.

replysharereportpermalink
u/zeynep_weiss59 points·1 year ago

STEP-1 averaged just under 15% at 68 weeks, so a 10% year is not a failure

replysharereportpermalink
u/teodor_duarte259 points·1 year ago

Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose. The distinction matters for anyone reading this later.

replysharereportpermalink
u/yara_boateng85 points·1 year ago

dose day drift of a day either way is fine, the curve barely notices

replysharereportpermalink
u/coa_janitormod · c/coa71 points·1 year ago

Sceptical of the mechanism you are proposing. Gastric emptying slows, it does not stop, and the timings you describe do not follow from it.

replysharereportpermalink
u/iman_castellanos41 points·1 year ago

Sceptical of the mechanism you are proposing.

Disagree with this specific line. A pause at 0.5mg is not evidence that 0.5mg has stopped working.

replysharereportpermalink
u/zeynep_zielinski21 points·1 year ago

the scale is the least sensitive instrument you own

replysharereportpermalink
u/customs_seizure_sid54 points·1 year ago

nausea that arrives on day two and fades by day four is the standard shape

replysharereportpermalink

← back to the whole thread

About c/semaglutide

Everything semaglutide: branded pens, compounded vials, oral formulations and the research-grade material people reconstitute themselves. Titration schedules, side-effect management, plateau troubleshooting and long-term maintenance. Dose questions are welcome; "what dose should I take" answers are not, because nobody here is your prescriber.

215kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/semaglutide rules
  1. No requests for a personal dose recommendation — describe what you did, not what someone else should do.
  2. Results posts need a timeframe and a starting point, or they get removed as unverifiable.
  3. Brand, compounded and research-grade material are all on-topic. Sourcing requests are not — that is c/vendorvetting.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.